Structured Patient Education Versus Written Information for Patients With Irritable Bowel Syndrome
1 other identifier
interventional
143
1 country
1
Brief Summary
In this randomized controlled study in patients with irritable bowel syndrome (IBS) we plan to compare the effects of a structured patient group education (IBS school) with receiving only written information in the form of a IBS-guidebook. The effects of the interventions on GI and psychological symptom severity, knowledge and quality of life will be assessed with validated questionnaires at baseline and 3 and 6 months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 25, 2008
CompletedFirst Posted
Study publicly available on registry
June 30, 2008
CompletedJuly 20, 2011
June 1, 2008
3.8 years
June 25, 2008
July 19, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect on GI symptoms as measured by IBS-SSS
Basleline and 3 and 6 months
Secondary Outcomes (1)
Effects on Quality of life (IBSQOL), Psychological symptoms (HAD), GI specific anxiety (VSI) and knowledge about IBS.
Baseline, 3 and 6 months
Study Arms (2)
1
ACTIVE COMPARATORStructured patients group intervention - IBS school
2
ACTIVE COMPARATORWritten information - IBS-guidebook
Interventions
Eligibility Criteria
You may qualify if:
- Men and women 18 to 70 years old, with IBS according to the Rome II criteria
- Written informed consent
You may not qualify if:
- An organic GI disease and/or with another disease potentially affecting the GI symptoms
- Severe psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept of Internal Medicine, Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Magnus Simrén, MD, PhD
Sahlgrenska University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 25, 2008
First Posted
June 30, 2008
Study Start
August 1, 2004
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
July 20, 2011
Record last verified: 2008-06